Clinical Trial Update: Phase III Clinical Study to Evaluate the Efficacy and Safety of the Combination of Lercanidipine/Valsartan in Hypertensive Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of a fixed-dose combination of lercanidipine/valsartan in adults with hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Lercanidipine (lercanidipine)
• VALSARTAN (Valsartan)

Snippet

Sponsor: LG Life Sciences | Conditions: Hypertension | Phase 3 | Status: COMPLETED